Home » Helix Therapeutics Handed $2.5 Million in New Funding
Helix Therapeutics Handed $2.5 Million in New Funding
Helix Therapeutics LLC, a New Haven, Conn.-based biopharmaceutical company, has landed $2.5 million in new funding from venture firm Canaan Partners and the quasi-public state funding entity Connecticut Innovations.
Mass High Tech
Mass High Tech
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May